BIRC7 and renal cell carcinoma: RETRACTION: H. Xu, S. Wu, X. Shen, Z. Shi, D. Wu, Y. Yuan, W. Jiang, Q. Wang, Q. Ke, Q. Mao, X. Li, Y. Liu, P. Yuan, Q. Zhang, E. Huang, and X. Chen, “Methylation‐Mediated miR‐214 Regulates Proliferation and Drug Sensitivity of Renal Cell Carcinoma Cells Through Targeting LIVIN,” Journal of Cellular and Molecular Medicine 24, no. 11 (2020): 6410–6425, https://doi.org/10.1111/jcmm.15287.